These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 20596704)

  • 41. Discriminating Depth of Response to Therapy in Multiple Myeloma Using Whole-body Diffusion-weighted MRI with Apparent Diffusion Coefficient: Preliminary Results From a Single-center Study.
    Wu C; Huang J; Xu WB; Guan YJ; Ling HW; Mi JQ; Yan H
    Acad Radiol; 2018 Jul; 25(7):904-914. PubMed ID: 29373210
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The distribution of the apparent diffusion coefficient as an indicator of the response to chemotherapeutics in ovarian tumour xenografts.
    Tourell MC; Shokoohmand A; Landgraf M; Holzapfel NP; Poh PS; Loessner D; Momot KI
    Sci Rep; 2017 Feb; 7():42905. PubMed ID: 28220831
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diffusion-weighted imaging: Apparent diffusion coefficient histogram analysis for detecting pathologic complete response to chemoradiotherapy in locally advanced rectal cancer.
    Choi MH; Oh SN; Rha SE; Choi JI; Lee SH; Jang HS; Kim JG; Grimm R; Son Y
    J Magn Reson Imaging; 2016 Jul; 44(1):212-20. PubMed ID: 26666560
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Apparent diffusion coefficient maps integrated in whole-body MRI examination for the evaluation of tumor response to chemotherapy in patients with multiple myeloma.
    Bonaffini PA; Ippolito D; Casiraghi A; Besostri V; Franzesi CT; Sironi S
    Acad Radiol; 2015 Sep; 22(9):1163-71. PubMed ID: 26182979
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multiple mathematical models of diffusion-weighted magnetic resonance imaging combined with prognostic factors for assessing the response to neoadjuvant chemotherapy and radiation therapy in locally advanced rectal cancer.
    Liang CY; Chen MD; Zhao XX; Yan CG; Mei YJ; Xu YK
    Eur J Radiol; 2019 Jan; 110():249-255. PubMed ID: 30599868
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ocular adnexal lymphoma: diffusion-weighted mr imaging for differential diagnosis and therapeutic monitoring.
    Politi LS; Forghani R; Godi C; Resti AG; Ponzoni M; Bianchi S; Iadanza A; Ambrosi A; Falini A; Ferreri AJ; Curtin HD; Scotti G
    Radiology; 2010 Aug; 256(2):565-74. PubMed ID: 20656841
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prediction of pathologic response to neoadjuvant chemotherapy in patients with breast cancer using diffusion-weighted imaging and MRS.
    Shin HJ; Baek HM; Ahn JH; Baek S; Kim H; Cha JH; Kim HH
    NMR Biomed; 2012 Dec; 25(12):1349-59. PubMed ID: 22566277
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Monitoring Tumor Volume in Patients With Prostate Cancer Undergoing Active Surveillance: Is MRI Apparent Diffusion Coefficient Indicative of Tumor Growth?
    Morgan VA; Parker C; MacDonald A; Thomas K; deSouza NM
    AJR Am J Roentgenol; 2017 Sep; 209(3):620-628. PubMed ID: 28609110
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Apparent diffusion coefficient: potential imaging biomarker for prediction and early detection of response to chemotherapy in hepatic metastases.
    Cui Y; Zhang XP; Sun YS; Tang L; Shen L
    Radiology; 2008 Sep; 248(3):894-900. PubMed ID: 18710982
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical relevance of the apparent diffusion coefficient value of metastatic bone tumours on diffusion-weighted MRI images: differences according to the types of primary tumour, the affected bones, and clinical factors.
    Cha MJ; Yoon YC
    Clin Radiol; 2015 Oct; 70(10):1116-21. PubMed ID: 26145186
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diffusion-weighted MR imaging: pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer.
    Park SH; Moon WK; Cho N; Song IC; Chang JM; Park IA; Han W; Noh DY
    Radiology; 2010 Oct; 257(1):56-63. PubMed ID: 20851939
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pretreatment apparent diffusion coefficient does not predict therapy response to neoadjuvant chemotherapy in breast cancer.
    Surov A; Wienke A; Meyer HJ
    Breast; 2020 Oct; 53():59-67. PubMed ID: 32652460
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Apparent diffusion coefficient measurements as very early predictive markers of response to chemotherapy in hepatic metastasis: a preliminary investigation of reproducibility and diagnostic value.
    Deckers F; De Foer B; Van Mieghem F; Botelberge T; Weytjens R; Padhani A; Pouillon M
    J Magn Reson Imaging; 2014 Aug; 40(2):448-56. PubMed ID: 24924334
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diffusion-weighted imaging of breast lesions: Region-of-interest placement and different ADC parameters influence apparent diffusion coefficient values.
    Bickel H; Pinker K; Polanec S; Magometschnigg H; Wengert G; Spick C; Bogner W; Bago-Horvath Z; Helbich TH; Baltzer P
    Eur Radiol; 2017 May; 27(5):1883-1892. PubMed ID: 27578047
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Microstructural characterization of normal and malignant human prostate tissue with vascular, extracellular, and restricted diffusion for cytometry in tumours magnetic resonance imaging.
    Panagiotaki E; Chan RW; Dikaios N; Ahmed HU; O'Callaghan J; Freeman A; Atkinson D; Punwani S; Hawkes DJ; Alexander DC
    Invest Radiol; 2015 Apr; 50(4):218-27. PubMed ID: 25426656
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diffusion-weighted imaging: Effects of intravascular contrast agents on apparent diffusion coefficient measures of breast malignancies at 3 Tesla.
    Nguyen VT; Rahbar H; Olson ML; Liu CL; Lehman CD; Partridge SC
    J Magn Reson Imaging; 2015 Sep; 42(3):788-800. PubMed ID: 25611726
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Contrast-enhanced dynamic and diffusion-weighted MR imaging at 3.0T to assess aggressiveness of bladder cancer.
    Zhou G; Chen X; Zhang J; Zhu J; Zong G; Wang Z
    Eur J Radiol; 2014 Nov; 83(11):2013-8. PubMed ID: 25213829
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of different MRI sequences in lesion detection and early response evaluation of diffuse large B-cell lymphoma--a whole-body MRI and diffusion-weighted imaging study.
    Wu X; Nerisho S; Dastidar P; Ryymin P; Järvenpää R; Pertovaara H; Eskola H; Kellokumpu-Lehtinen PL
    NMR Biomed; 2013 Sep; 26(9):1186-94. PubMed ID: 23483722
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diffusion MRI for prediction of response of rectal cancer to chemoradiation.
    Dzik-Jurasz A; Domenig C; George M; Wolber J; Padhani A; Brown G; Doran S
    Lancet; 2002 Jul; 360(9329):307-8. PubMed ID: 12147376
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pancreatic cancer: lack of association between apparent diffusion coefficient values and adverse pathological features.
    Rosenkrantz AB; Matza BW; Sabach A; Hajdu CH; Hindman N
    Clin Radiol; 2013 Apr; 68(4):e191-7. PubMed ID: 23312674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.